Envestnet Portfolio Solutions’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Buy
4,758
+413
+10% +$141K 0.01% 513
2025
Q4
$1.73M Buy
4,345
+3,018
+227% +$1.34M 0.01% 580
2025
Q3
$605K Buy
1,327
+163
+14% +$66.4K ﹤0.01% 955
2025
Q2
$380K Buy
1,164
+297
+34% +$82.2K ﹤0.01% 1232
2025
Q1
$234K Sell
867
-1,195
-58% -$307K ﹤0.01% 1413
2024
Q4
$485K Buy
2,062
+880
+74% +$231K ﹤0.01% 1258
2024
Q3
$325K Buy
1,182
+43
+4% +$11.2K ﹤0.01% 1406
2024
Q2
$277K Sell
1,139
-270
-19% -$42.6K ﹤0.01% 1425
2024
Q1
$211K Buy
1,409
+41
+3% +$6.84K ﹤0.01% 1545
2023
Q4
$262K Buy
1,368
+89
+7% +$15.2K ﹤0.01% 1366
2023
Q3
$227K Buy
+1,279
New +$244K ﹤0.01% 1375

Other funds holding ALNY